Pharmaceutical Research

, Volume 25, Issue 10, pp 2250–2261 | Cite as

Investigations on the Humidity-Induced Transformations of Salbutamol Sulphate Particles Coated with l-Leucine

  • Janne Raula
  • Frank Thielmann
  • Jarno Kansikas
  • Sami Hietala
  • Minna Annala
  • Jukka Seppälä
  • Anna Lähde
  • Esko I. Kauppinen
Research Paper

Abstract

Purpose

The crystallization and structural integrity of micron-sized inhalable salbutamol sulphate particles coated with l-leucine by different methods are investigated at different humidities. The influence of the l-leucine coating on the crystallization of salbutamol sulphate beneath the coating layer is explored.

Methods

The coated particles are prepared by an aerosol flow reactor method, the formation of the l-leucine coating being controlled by the saturation conditions of the l-leucine. The coating is formed by solute diffusion within a droplet and/or by vapour deposition of l-leucine. The powders are humidified at 0%, 44%, 65% and 75% of relative humidity and the changes in physical properties of the powders are investigated with dynamic vapour sorption analysis (DVS), a differential scanning calorimeter (DSC), and a scanning electron microscope (SEM).

Results

Visual observation show that all the coated particles preserve their structural integrity whereas uncoated salbutamol sulphate particles are unstable at 65% of relative humidity. The coating layer formed by diffusion performs best in terms of its physical stability against moisture and moisture-induced crystallization. The degree of crystallization of salbutamol in the as-prepared powders is within the range 24–35%. The maximum degree of crystallization after drying ranges from 55 to 73% when the salbutamol crystallizes with the aid of moisture. In addition to providing protection against moisture, the l-leucine coating also stabilizes the particle structure against heat at temperatures up to 250°C.

Conclusion

In order to preserve good flowability together with good physical stability, the best coating would contain two l-leucine layers, the inner layer being formed by diffusion (physical stability) and the outer layer by vapour deposition (flowability).

KEY WORDS

crystallization humidity l-leucine coating salbutamol sulphate stability 

Notes

Acknowledgements

We thank the Academy of Finland for financial support. Graduate student Raita Heiskanen is thanked for assistance with the experimental work.

References

  1. 1.
    G. Buckton, P. Darcy, D. Greenleaf, and P. Holbrook. The use of isothermal microcalorimetry in the study of changes in crystallinity of spray-dried salbutamol sulphate. Int. J. Pharm. 116:113–118 (1995).CrossRefGoogle Scholar
  2. 2.
    B. C. Hancock, and G. Zografi. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86:1–12 (1997)and references therein.PubMedCrossRefGoogle Scholar
  3. 3.
    R. Surana, A. Pyne, and R. Suryanarayanan. Effect of aging on the physical properties of amorphous trehalose. Pharm. Res. 21:867–874 (2004).PubMedCrossRefGoogle Scholar
  4. 4.
    N. Rodrigues-Hornedo, D. Lechuga-Ballesteros, and H. J. Wu. Phase transition and heterogeneous/epiaxial nucleation of hydrated and anhydrous theophylline crystals. Int. J. Pharm. 85:149–162 (1992).CrossRefGoogle Scholar
  5. 5.
    V. K. Kakumanu, and A. K. Bansal. Enthalpy relaxation studies of Celecoxib amorphous mixtures. Pharm. Res. 19:1873–1878 (2002).PubMedCrossRefGoogle Scholar
  6. 6.
    M. Yoshioka, B. C. Hancock, and G. Zografi. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. J. Pharm. Sci. 84:983–986 (1995).PubMedCrossRefGoogle Scholar
  7. 7.
    L. Yu, D. S. Mishra, and D. R. Rigsbee. Determination of the glass properties of D-mannitol using sorbitol as an impurity. J. Pharm. Sci. 87:774–777 (1998).PubMedCrossRefGoogle Scholar
  8. 8.
    N. Y. K. Chew, and H.-K. Chan. Use of solid corrugated particles to enhance powder aerosol performance. Pharm. Res. 18:1570–1577 (2001).PubMedCrossRefGoogle Scholar
  9. 9.
    N. Y. K Chew, B. Y. Shekunov, H. H. Y. Tong, A. H. L. Chow, C. Savage, J. Wu, and H.-K. Chan. Effect of amino acids on the dispersion of disodium cromoglycate powders. J. Pharm. Sci. 94:2289–2300 (2005).CrossRefGoogle Scholar
  10. 10.
    A. M. Abdul-Fattah, V. Truong-Le, L. Yee, E. Pan, Y. Ao, D. S. Kalonia, and M. J. Pikal. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability II: Stability of a vaccine. Pharm. Res. 24:715–727 (2007).PubMedCrossRefGoogle Scholar
  11. 11.
    J. Calderon De Anda, X. Z. Wang, X. Lai, and K. J. Roberts. Classifying organic crystals via in-process image analysis and the use of monitoring charts to follow polymorphic and morphological changes. J. Process Control. 15:785–797 (2005).CrossRefGoogle Scholar
  12. 12.
    J.-F. Willart, J. Lefebvre, F. DaneÌde, S. Comini, P. Looten, and M. Descamps. Polymorphic transformation of the G-form of d-sorbitol upon milling: structural and nanostructural analyses. Solid State Commun. 135:519–524 (2005).CrossRefGoogle Scholar
  13. 13.
    D. Begon, P. Guillaume, and M. Kohl. Process for producing fine medicinal substances. WO World IPO 0114036 (2001).Google Scholar
  14. 14.
    R. W. Lancaster, H. Sigh, and A. L. Theophilus. Apparatus and process for preparing crystalline particles. WO World IPO 0038811 (2000).Google Scholar
  15. 15.
    B. Y. Shekunov, S. Bristow, A. H. L. Chow, L. Cranswick, D. J. W. Grant, and P. York. Formation of composite crystals by precipitation in supercritical CO2. Cryst. Growth Des. 3:603–610 (2003).CrossRefGoogle Scholar
  16. 16.
    L.-E. Briggner, K. Bystrom, E. Jakupovic, E. Trofast, and J. Trofast. Pharmaceutical formulation. US Patent 5,874,063 (2002).Google Scholar
  17. 17.
    B. Hancock, and G. Zografi. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm. Res. 11:471–477 (1994).PubMedCrossRefGoogle Scholar
  18. 18.
    K. D. Kussendrager, and M. J. H. Ellison. Carrier material for dry powder inhalation. WO 02/07705 (2002).Google Scholar
  19. 19.
    G. H. Ward, and R. K. Schultz. Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability. Pharm. Res. 12:773–779 (1995).PubMedCrossRefGoogle Scholar
  20. 20.
    K. Dick, T. Dhanasekaran, Z. Zhang, and D. Meisel. Size-dependent melting of silica-encapsulated gold nanoparticles. J. Am. Chem. Soc. 124:2312–2317 (2002).PubMedCrossRefGoogle Scholar
  21. 21.
    J. Raula, A. Kuivanen, A. Lähde, and E. I. Kauppinen. Gas-phase synthesis of L-leucine-coated micrometer-sized salbutamol sulphate sodium chloride particles. Powder Technol., DOI  10.1016/j.powtec.2008.03.006 (2008).
  22. 22.
    J. Glinski, G. Chavepeyer, and J.-K. Platten. Surface properties of aqueous solutionss of L-leucine. Biophys. Chem. 84:99–103 (2000).CrossRefGoogle Scholar
  23. 23.
    N. Matubayasi, H. Miyamoto, J. Namihira, K. Yano, and T. Tanaka. Thermodynamic quantities of surface formation of aqueous electrolyte solutions V. Aqueous solutions of aliphatic amino acids. J. Colloid Interface Sci. 250:431–437 (2002).PubMedCrossRefGoogle Scholar
  24. 24.
    J. Raula, A. Lähde, and E. I. Kauppinen. A novel gas phase method for the combined synthesis and coating of pharmaceutical particles. Pharm. Res. 25:242–245 (2008).Google Scholar
  25. 25.
    H. Eerikäinen, W. Watanabe, E. I. Kauppinen, and P. P. Ahonen. Aerosol flow reactor method for synthesis of drug nanoparticles. Eur. J. Pharm. Biopharm. 55:357–360 (2003).PubMedCrossRefGoogle Scholar
  26. 26.
    J. Raula, H. Eerikäinen, and E. I. Kauppinen. Influence of the solvent composition on the morphology of polymer drug composite nanoparticles. Int. J. Pharm. 284:13–21 (2004).PubMedCrossRefGoogle Scholar
  27. 27.
    Y. Zhu, and K. W. Lee. Experimental study on small cyclones operating at high flow rates. J. Aerosol Sci. 30:1303–1315 (1999).CrossRefGoogle Scholar
  28. 28.
    H. J. Svec, and D. D. Clyde. Vapour pressures of some alpha-amino acids. J. Chem. Eng. Data. 10:151–152 (1965).CrossRefGoogle Scholar
  29. 29.
    F. P. Incropera, and D. P. DeWitt. Fundamentals of Heat and Mass Transfer. 5Wiley, New York, 2002, pp. 846–847.Google Scholar
  30. 30.
    R. J. Lang. Ultrasonic atomization of liquids. J. Acoust. Soc. Am. 1:6 (1962).CrossRefGoogle Scholar
  31. 31.
    R. C. Flagan, and J. H. Seinfeld. Fundamentals of Air Pollution Engineering. Prentice Hall, Englewood Cliffs, 1988, p. 542.Google Scholar
  32. 32.
    J. Raula, J. A. Kurkela, D. P. Brown, and E. I. Kauppinen. Study of the dispersion behaviour of L-leucine containing microparticles synthesized with an aerosol flow reactor method. Powder Technol. 177:125–132 (2007).CrossRefGoogle Scholar
  33. 33.
    J. Raula, A. Kuivanen, A. Lähde, and E. I. Kauppinen. Synthesis of L-leucine nanoparticles via physical vapor deposition under various saturation conditions. J. Aerosol Sci. 38:1172–1184 (2007).Google Scholar
  34. 34.
    A. Columbano, G. Buckton, and P. Wikeley. A study of the crystallisation of amorphous salbutamol sulphate using water vapour sorption and near infrared spectroscopy. Int. J. Pharm. 237:171–178 (2002).PubMedCrossRefGoogle Scholar
  35. 35.
    D. J. Burnett, F. Thielmann, and J. Booth. Determining the critical relative humidity for moisture-induced phase transitions. Int. J. Pharm. 287:123–133 (2004).PubMedCrossRefGoogle Scholar
  36. 36.
    G. Buckton, and P. Darcy. The use of gravimetric studies to assess the degree of crystallinity of predominantly crystalline powders. Int. J. Pharm. 123:265–271 (1995).CrossRefGoogle Scholar
  37. 37.
    H. Larhrib, G. P. Martin, C. Marriott, and D. Prime. The influence of carrier and drug morphology on drug delivery from dry powder formulations. Int. J. Pharm. 257:283–296 (2003).PubMedCrossRefGoogle Scholar
  38. 38.
    T. S. Martins, J. R. Matos, G. Vicentini, and P. C. Isolani. Synthesis, characterization, spectroscopy and thermal analysis of rare earth picrate complexes with L-leucine. J. Therm. Anal. Calorim. 86:351–357 (2006).CrossRefGoogle Scholar
  39. 39.
    J. Li, Z. Wang, X. Yanga, L. Hua, Y. Liu, and C. Wang. Decomposing or subliming? An investigation of thermal behavior of L-leucine. Thermochim. Acta. 447:147–153 (2006).CrossRefGoogle Scholar
  40. 40.
    S. Budavari, M. J. O’Neil, A. Smith, and P. E. Heckelman (Eds.). The Merck Index, 11th edn., Rahway, USA, 1989, p. 857.Google Scholar
  41. 41.
    D. O. Corrigan, O. I. Corrigan, and A. M. Healy. Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systems. Int. J. Pharm. 273:171–182 (2004).PubMedCrossRefGoogle Scholar
  42. 42.
    H. Eerikäinen, L. Peltonen, J. Raula, E. I. Kauppinen, and J. Hirvonen. Nanoparticles containing ketoprofen and acrylic polymers prepared by an aerosol flow reactor method. AAPS Pharm. Sci. Tech. 5:68 (2004).CrossRefGoogle Scholar
  43. 43.
    Q. Jiang, H. X. Shi, and M. Zhao. Melting thermodynamics of organic nanocrystals. J. Chem. Phys. 111:2176–2180 (1999).CrossRefGoogle Scholar
  44. 44.
    Q. Jiang, Z. Zhang, and J. C. Li. Melting thermodynamics of nanocrystals embedded in a matrix. Acta Mater. 48:4791–4795 (2000).CrossRefGoogle Scholar
  45. 45.
    S. L. Lai, J. Y. Guo, V. Petrova, G. Ramanath, and L. H. Allen. Size-dependent melting properties of small tin particles: nanocalorimetric measurements. Phys. Rev. Lett. 77:99–102 (1996).PubMedCrossRefGoogle Scholar
  46. 46.
    M. Zhao, and Q. Jiang. Melting and surface melting of low-dimensional In crystals. Solid State Commun. 130:37–39 (2004).CrossRefGoogle Scholar
  47. 47.
    D. V. Talapin, A. L. Rogach, A. Kornowski, M. Haase, and H. Weller. Highly luminescent monodisperse CdSe and CdSe/ZnS nanocrystals synthesized in a hexadecylamine–trioctylphosphine oxide–trioctylphospine mixture. Nanoletters. 1:207–211 (2001).Google Scholar
  48. 48.
    A. M. Abdul-Fattah, K. M. Dellerman, R. H. Bogner, and M. J. Pikal. The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam. J. Pharm. Sci. 96:1237–1250 (2007).PubMedCrossRefGoogle Scholar
  49. 49.
    J. Liu, D. R. Rigsbee, C. Stotz, and M. J. Pikal. Dynamics of pharmaceutical amorphous solids: the study of enthalpy relaxation by isothermal microcalorimetry. J. Pharm. Sci. 91:1853–1862 (2002).PubMedCrossRefGoogle Scholar
  50. 50.
    V. B. Pokharkar, L. P. Mandpe, M. N. Padamwar, A. A. Ambike, K. R. Mahadik, and A. Paradkar. Development, characterization and stabilization of amorphous form of a low T g drug. Powder Technol. 167:20–25 (2006).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Janne Raula
    • 1
  • Frank Thielmann
    • 2
  • Jarno Kansikas
    • 3
  • Sami Hietala
    • 4
  • Minna Annala
    • 5
  • Jukka Seppälä
    • 5
  • Anna Lähde
    • 1
  • Esko I. Kauppinen
    • 1
    • 6
  1. 1.NanoMaterials Group, Laboratory of Physics and Center for New MaterialsHelsinki University of Technology (TKK)TKKFinland
  2. 2.Surface Measurement Systems Ltd.LondonUK
  3. 3.Laboratory of Inorganic ChemistryUniversity of HelsinkiHelsinkiFinland
  4. 4.Laboratory of Polymer ChemistryUniversity of HelsinkiHelsinkiFinland
  5. 5.Laboratory of Polymer TechnologyHelsinki University of Technology (TKK)TKKFinland
  6. 6.VTT Biotechnology (VTT)EspooFinland

Personalised recommendations